Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Neuroendocrine × niraparib × 90 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 9 Prostatic Neoplasms 6 Neoplasm Metastasis 5 Breast Neoplasms 5 Neoplasms 4 Fallopian Tube Neoplasms 4 Pancreatic Neoplasms 3 Glioblastoma 3 Prostatic Neoplasms, Castration-Resistant 2 Glioma 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Unilateral Breast Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 SCLC,Extensive Stage 1 Prostate Adenocarcinoma 1 Pathologic Complete Response 1 Osteosarcoma 1 Neuroblastoma 1 Metastatic Castration-sensitive Prostate Cancer 1 Lung Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Hemangiosarcoma 1 Endometrial Neoplasms 1 Disease Progression 1 Colorectal Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

atezolizumab 3 Etoposide 2 Cisplatin 2 zimberelimab 1 tivozanib 1 durvalumab 1 cabozantinib 1 belinostat 1 Temozolomide 1 Standard of Care 1 Positron Emission Tomography Computed Tomography 1 Nivolumab 1 Magnetic Resonance Imaging 1 Ipilimumab 1 Immunoglobulin G 1 Disulfides 1 Carboplatin 1 Capecitabine 1 CTLA-4 Antigen 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡